Fig. 5From: Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancerFlow diagram revealing the study design. %RVT, per cent of residual viable tumourBack to article page